SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-004549
Filing Date
2024-01-08
Accepted
2024-01-08 17:16:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d685905ddefa14a.htm DEFA14A 20430
  Complete submission text file 0001193125-24-004549.txt   21492
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38800 | Film No.: 24521052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)